Eric Racine is vice president, global patient advocacy for Sanofi. He is responsible for Sanofi’s worldwide patient advocacy strategy to enhance the company’s commitment to patient centricity and strengthen how Sanofi partners with patient advocates. Eric joined Sanofi in 2002 and has held progressive leadership positions spanning medical marketing, market access, healthcare policy and corporate affairs.
Before he joined the pharmaceutical industry, Eric held various academic, clinical and management positions. He has a doctor of pharmacy degree from Wayne State University in Michigan and an executive MBA from Rutgers University.
Jeffrey Rein is the retired chairman and chief executive officer for Walgreens, the nation’s largest drugstore chain. He joined the company as an assistant store manager in 1982. After several increasingly responsible positions, in 2006 he became CEO. He's a UA graduate, earning his accounting degree in 1974 and his pharmacy degree in 1980, He serves on the board of directors for the Meijer Company, Midtown Educational Foundation, Midwest Young Artists and University of Arizona Eller College National Advisory Board.
Mary J. Ryan is an emeritus board member who worked for Medco Health Solutions, Inc., from 1988 until 2012. She is retired as vice president, corporate regulatory group, responsible for interface with various regulatory agencies, including state boards of pharmacy and departments of insurance. Mary graduated from UA with a bachelor of science in pharmacy in 1974. She completed her master’s degree in business administration at Arizona State University in 1983. She is a member of the American Pharmacists Association and the chair of the Legislative and Regulatory Action Committee at the Academy of Managed Care Pharmacy.
Bruce Seligmann is the co-founder and CSO of BioSpyder Technologies, Inc., and is conducting research in collaboration with the University of Arizona Cancer Center. He's also the co-founder, director, chief science officer and vice president of research at High Throughput Genomics based in Tucson. Through his work, Bruce has provided time-and cost-saving technology that assists the advancement of research, drug discovery and the development of better therapies and diagnostics. Bruce is also the founder of Systems Integration Drug Discovery Co., which was sold to Discovery Partners International. Before that, he was the vice president of research and development and the center director at the biotech company Selectide.